Literature DB >> 25614309

Morphology and function of cerebral arteries in adults with pompe disease.

Ole Hensel1, F Hanisch, K Stock, D Stoevesandt, M Deschauer, T Müller.   

Abstract

OBJECTIVE: Cerebrovascular abnormalities have been reported in adult patients with Pompe disease. The objective was to study these abnormalities by (1) determining the diameter and mean flow velocity (MFV) of large cerebral arteries and (2) estimating cerebral blood flow (CBF), resistance index (RI) and cerebrovascular reactivity (CVR) as functions of resistance vessels.
METHODS: In ten adults with Pompe disease and twenty controls, the diameter, peak systolic (PSV) and end-diastolic velocities (EDV) of arteries supplying the brain were quantified by MR angiography and sonography. MFV, RI and CBF were calculated. CVR in the middle cerebral artery (MCA) was determined by hyperventilation and acetazolamide injection.
RESULTS: MR angiography revealed dilation of cerebral arteries predominantly in the posterior circulation. Dilative arteriopathy was found in three patients; two of them showed vertebrobasilar dolichoectasia. Despite of the dilative arteriopathy, the MFV was normal, indicating increased CBF and dilated resistance vessels. RI of all examined arteries and CVR of MCA were normal.
CONCLUSION: The data suggest that dilation of small and large cerebral arteries is a common feature in adults with Pompe disease. Increased CBF might be the consequence of dilated resistance vessels. However, dysfunction of resistance vessels was rarely found. SYNOPSIS: In adults with Pompe disease, dilation of small and large cerebral arteries is a common feature and might be associated with increased cerebral blood flow.

Entities:  

Year:  2015        PMID: 25614309      PMCID: PMC4375123          DOI: 10.1007/8904_2014_385

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  19 in total

1.  Arterial enlargement, tortuosity, and intimal thickening in response to sequential exposure to high and low wall shear stress.

Authors:  Eiketsu Sho; Hiroshi Nanjo; Mien Sho; Mikio Kobayashi; Masayo Komatsu; Koichi Kawamura; Chengpei Xu; Christopher K Zarins; Hirotake Masuda
Journal:  J Vasc Surg       Date:  2004-03       Impact factor: 4.268

2.  Intracranial dilative arteriopathy is associated with chronic kidney disease and small vessel diseases in the elderly.

Authors:  Hiroo Ichikawa; Nobuyoshi Takahashi; Masanori Mukai; Hirotaka Katoh; Tadao Akizawa; Mitsuru Kawamura
Journal:  J Stroke Cerebrovasc Dis       Date:  2009 Nov-Dec       Impact factor: 2.136

Review 3.  Mechanical properties of arteries

Authors:  P B Dobrin
Journal:  Physiol Rev       Date:  1978-04       Impact factor: 37.312

4.  Type II glycogenosis. Biochemical and electron microscopic study.

Authors:  J C Garancis
Journal:  Am J Med       Date:  1968-02       Impact factor: 4.965

5.  Endothelial-mediated regulation of cerebral microcirculation.

Authors:  R M McCarron; Y Chen; T Tomori; A Strasser; R Mechoulam; E Shohami; M Spatz
Journal:  J Physiol Pharmacol       Date:  2006-11       Impact factor: 3.011

6.  Aneurysms and vacuolar degeneration of cerebral arteries in late-onset acid maltase deficiency.

Authors:  H A Kretzschmar; H Wagner; G Hübner; A Danek; T N Witt; P Mehraein
Journal:  J Neurol Sci       Date:  1990-09       Impact factor: 3.181

7.  Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease.

Authors:  Sabrina Sacconi; Jonathan D Bocquet; Stéphane Chanalet; Véronique Tanant; Leonardo Salviati; Claude Desnuelle
Journal:  J Neurol       Date:  2010-06-18       Impact factor: 4.849

8.  The clinical picture of ectasia of the intracerebral arteries.

Authors:  Y L Yu; I F Moseley; P Pullicino; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-01       Impact factor: 10.154

9.  Late-onset acid maltase deficiency associated with intracranial aneurysm.

Authors:  Y Matsuoka; Y Senda; M Hirayama; T Matsui; A Takahashi
Journal:  J Neurol       Date:  1988-07       Impact factor: 4.849

10.  Increased aortic stiffness and blood pressure in non-classic Pompe disease.

Authors:  Stephan C A Wens; Esther Kuperus; Francesco U S Mattace-Raso; Michelle E Kruijshaar; Esther Brusse; Kees C A G M van Montfort; Marjan Scheltens- de Boer; Eric J G Sijbrands; Ans T van der Ploeg; Pieter A van Doorn
Journal:  J Inherit Metab Dis       Date:  2014-01-10       Impact factor: 4.982

View more
  10 in total

Review 1.  An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond.

Authors:  Aditi Korlimarla; Jeong-A Lim; Priya S Kishnani; Baodong Sun
Journal:  Ann Transl Med       Date:  2019-07

2.  Long term follow-up of cerebrovascular abnormalities in late onset Pompe disease (LOPD).

Authors:  Matteo Garibaldi; Sabrina Sacconi; Giovanni Antonini; Claude Desnuelle
Journal:  J Neurol       Date:  2017-01-24       Impact factor: 4.849

3.  Intracranial arterial dolichoectasia and superficial siderosis associated to neurofibromatosis type 1: report of one case.

Authors:  Tirso González-Pinto; Tomás Pérez Concha; Ana Moreno Estébanez
Journal:  Neurol Sci       Date:  2018-08-10       Impact factor: 3.307

Review 4.  A Multidisciplinary Perspective Addressing the Diagnostic Challenges of Late-Onset Pompe Disease in the Arabian Peninsula Region Developed From an Expert Group Meeting.

Authors:  Ali Al Shehri; Abdullah Al-Asmi; Abdullah Mohammed Al Salti; Abubaker Almadani; Ali Hassan; Ahmed K Bamaga; Edward J Cupler; Jasem Al-Hashel; Majed M Alabdali; Mohammed H Alanazy; Suzan Noori
Journal:  J Neuromuscul Dis       Date:  2022

5.  Late-onset Pompe disease: a genetic-radiological correlation on cerebral vascular anomalies.

Authors:  A Pichiecchio; S Sacco; P De Filippi; E Caverzasi; S Ravaglia; S Bastianello; C Danesino
Journal:  J Neurol       Date:  2017-08-30       Impact factor: 4.849

6.  Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease.

Authors:  Manuela Corti; Cristina Liberati; Barbara K Smith; Lee Ann Lawson; Ibrahim S Tuna; Thomas J Conlon; Kirsten E Coleman; Saleem Islam; Roland W Herzog; David D Fuller; Shelley W Collins; Barry J Byrne
Journal:  Hum Gene Ther Clin Dev       Date:  2017-12       Impact factor: 5.032

7.  Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD).

Authors:  Federica Montagnese; Francesca Granata; Olimpia Musumeci; Carmelo Rodolico; Stefania Mondello; Emanuele Barca; Maria Cucinotta; Anna Ciranni; Marcello Longo; Antonio Toscano
Journal:  J Inherit Metab Dis       Date:  2016-02-01       Impact factor: 4.982

8.  Decreased outlet angle of the superior cerebellar artery as indicator for dolichoectasia in late onset Pompe disease.

Authors:  Ole Hensel; Ilka Schneider; Mathias Wieprecht; Torsten Kraya; Stephan Zierz
Journal:  Orphanet J Rare Dis       Date:  2018-04-13       Impact factor: 4.123

9.  Renal artery fibromuscular dysplasia in Pompe disease: A case report.

Authors:  Evangelia Pappa; Constantinos Papadopoulos; Philippe Grimbert; Pascal Laforêt; Guillaume Bassez
Journal:  Mol Genet Metab Rep       Date:  2018-07-26

10.  Glycogen accumulation in smooth muscle of a Pompe disease mouse model.

Authors:  Angela L McCall; Justin S Dhindsa; Aidan M Bailey; Logan A Pucci; Laura M Strickland; Mai K ElMallah
Journal:  J Smooth Muscle Res       Date:  2021
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.